Forced Degradation Studies — Stress Design for Stability-Indicating Methods

Forced degradation deliberately stresses a drug substance or product to reveal likely degradation pathways and demonstrate that analytical methods can separate degradants from the active. The goal is informative degradation, not destruction: over-stressed samples produce artefacts that mislead method development.

Target relevant stress conditions

Hydrolysis, oxidation, heat, humidity and light each probe different pathways; ICH Q1B addresses photostability specifically. Select conditions from the molecule's chemistry and the formulation, and aim for meaningful partial degradation rather than total decomposition. Record exact conditions, durations and observations so the study is reproducible.

Demonstrate separation and mass balance

The study should show that degradants are resolved from the active and quantified, with a mass-balance assessment explaining what was formed. Ask how peaks are tracked across conditions, how co-elution is excluded and which characterization (such as MS) supports degradant identification where needed.

Feed the results into the method and the dossier

Forced-degradation evidence underpins the claim that a method is stability-indicating and informs specification setting and formulation decisions. Agree the deliverable — a structured report with chromatograms, conditions and pathway discussion — rather than raw data alone. The study supports, but does not replace, formal stability programmes.

Sample considerations

  • Provide the substance/product, known chemistry, formulation and existing analytical methods.
  • State the purpose: method development support, characterization or dossier evidence.
  • Agree stress conditions, analysis plan, mass-balance approach and reporting format.

Questions to ask a laboratory

  • How are stress conditions selected and controlled for this molecule?
  • How are degradants tracked, separated and identified?
  • How will the study demonstrate the method is stability-indicating?

Laboratories with relevant capabilities

No directory profile currently documents this specific capability. Submit a request and we will look for laboratories that cover it.

Sources and scope references

ICH — quality guidelines

FDA — analytical procedures and methods validation guidance

Related testing briefs

Pharmaceutical Stability Testing

Dissolution Testing

Analytical Method Transfer

Related industry testing

Unified provider directory

Confirm standard edition, jurisdiction and actual laboratory scope. Service references are not partnerships or endorsements.

Request testing · Provider directory